MedPath

Evaluation of Hysterectomy After Chemoradiation Therapy for Stage IB2/II Cervical Cancer

Phase 3
Terminated
Conditions
Stage IB2 Cervical Cancer
Stage II Cervical Cancer
Adenocarcinoma
Squamous Cell Carcinoma
Adenosquamous Carcinoma
Interventions
Procedure: hysterectomy
Registration Number
NCT01363466
Lead Sponsor
UNICANCER
Brief Summary

GYNECO 02 hypothesis is that hysterectomy reduces the possibility of local or loco-regional relapse, especially in patient with a reduced metastatic risk and who received a local chemoradiation therapy with an increase of radiotherapy doses (45 grays).

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
Female
Target Recruitment
61
Inclusion Criteria
  • operable Stage IB2/II Cervical Cancer
  • adenocarcinoma, squamous cell or adenosquamous carcinoma
  • Patient between 18 and 70 years old
  • No lombo-aortic lymph node invasion at baseline
  • Previous 45 grays external pelvic radiation with concomitant chemotherapy (cisplatin 40 mg/m2/week corresponding to 5 cycles)
  • Followed by a 15 grays utero-vaginal brachytherapy, eventually combined with a 6th cycle of chemotherapy (cisplatin 40 mg/m2)
  • with a pelvic boost if lymph node or parametrial invasion
  • No macroscopic residual tumor after 6 to 8 weeks after brachytherapy.
Exclusion Criteria
  • Other tumor histology (neuro-endocrine)
  • Stage > II (FIGO 1995) at baseline
  • Patient with remaining cervical cancer (after sub-total hysterectomy)

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
with hysterectomyhysterectomy-
Primary Outcome Measures
NameTimeMethod
Relapse free survivalfrom randomization to relapse or last contact (up to 3 years)

There is a follow-up period of 3 years.

Secondary Outcome Measures
NameTimeMethod
Overall SurvivalFrom randomisation to death or last contact (up to 3 years)

There is a follow-up period of 3 years.

Trial Locations

Locations (35)

Clinique Sainte Thérèse de l'enfant Jésus

🇫🇷

Amiens, France

Clinique Axium

🇫🇷

Aix-en-Provence, France

Centre Hospitalier Universitaire

🇫🇷

Amiens, France

Centre Hospitalier Lyon Sud

🇫🇷

Lyon, France

Centre Hospitalier de Beauvais

🇫🇷

Beauvais, France

Institut Bergonié

🇫🇷

Bordeaux, France

Polyclinique du Parc Rambot

🇫🇷

Aix-en-Provence, France

Centre Paul Papin

🇫🇷

Angers, France

Centre Hospitalier Régional Universitaire La Timone

🇫🇷

Marseille, France

Centre Georges-François Leclerc

🇫🇷

Dijon, France

Centre Hospitalier Universitaire - Hôpital Arnaud de Villeneuve

🇫🇷

Montpellier, France

Centre Val d'Aurelle-Paul Lamarque

🇫🇷

Montpellier, France

Centre Hospitalier Nord Deux-Sèvres

🇫🇷

Bressuire Cedex, France

Centre Hospitalier Universitaire de Brest

🇫🇷

Brest, France

Centre Hospitalier Intercommunal

🇫🇷

Créteil, France

Centre Hospitalier de Fontainebleau

🇫🇷

Fontainebleau, France

Hôpital Hotel-Dieu

🇫🇷

Lyon Cedex 02, France

Centre Hospitalier Edouard Herriot

🇫🇷

Lyon, France

Centre Hospitalier Régional Universitaire Hôpital Nord

🇫🇷

Marseille, France

Centre hospitalier des Pays de Morlaix

🇫🇷

Morlaix, France

Centre René Gauducheau

🇫🇷

Nantes, France

Hôpital de la Source

🇫🇷

Orléans, France

Hôpital des Diaconnesses

🇫🇷

Paris Cedex 12, France

Hôpital Européen Georges Pompidou

🇫🇷

Paris Cedex 15, France

Centre Hospitalier Universitaire Jean Bernard

🇫🇷

Poitiers Cedex, France

Polyclinique de Courlancy

🇫🇷

Reims, France

Clinique Mutualiste de la Sagesse

🇫🇷

Rennes Cedex, France

Centre Universitaire Hospitalier- Hôpital Sud

🇫🇷

Rennes, France

Centre Henri Becquerel

🇫🇷

Rouen, France

Centre René Huguenin

🇫🇷

Saint-Cloud, France

Institut Claudius Régaud

🇫🇷

Toulouse Cedex, France

Centre Hospitalier Bretonneau

🇫🇷

Tours, France

Institut Gustave Roussy

🇫🇷

Villejuif, France

Hôpital de la conception

🇫🇷

Marseille cedex 5, France

Institut paoli Calmettes

🇫🇷

Marseille Cedex 09, France

© Copyright 2025. All Rights Reserved by MedPath